VAERS Explorer
Back to explore

Report #2824723

Received Feb 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
0.7 yrs
State
CA
Recovered
Recovered
Vaccinated
Jun 7, 2024
Onset
Jun 7, 2024
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICS1L7373IM / LL

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Physician ordered Menveo 1-vial formulation for 2-year old patient in preparation for upcoming travel out of the country. Vaccine administered by LVN as ordered. Menveo 1-vial formulation is FDA-approved for ages 10-55 years. The prescribing information states "Safety and effectiveness of the one-vial presentation of MENVEO in children aged younger than 10 years have not been established. For children 2 months through 9 years of age, only the two-vial presentation is approved for use." The order in record reads "Meningococcal MCV40 (MENVEO) - 1 vial (10-55yr)". The vial states "10 years through 55 Years of Age".

Current illness

None

Medical history

None

Other medications

None

Allergies

None

Lab data

None